Should we keep on doing robotic surgery to treat lung cancer in 2020? | Zendy

François Montagne | Zendy; JeanMarc Baste | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Should we keep on doing robotic surgery to treat lung cancer in 2020?

Author(s) -

François Montagne,

JeanMarc Baste

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.02.87

Subject(s) - medicine , lung cancer , robotic surgery , surgery , oncology

Department of General and Thoracic Surgery, Rouen University Hospital, Rouen, France; Department of General and Thoracic Surgery, Rouen University Hospital, Normandie University, Rouen, France Correspondence to: Jean-Marc Baste, MD, PhD. Department of General and Thoracic Surgery, 1 rue de Germont, 76000 Rouen, France. Email: jean-marc.baste@chu-rouen.fr. Provenance: This is an invited Editorial Commentary commissioned by the Section Editor Dr. Maria Rodriguez (Department of Thoracic Surgery, Clínica Universidad de Navarra, Madrid, Spain). Comment on: Spaggiari L, Sedda G, Maisonneuve P, et al. A Brief Report on Survival After Robotic Lobectomy for Early-Stage Lung Cancer. J Thorac Oncol 2019;14:2176-80.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research